Showing results (111-120 of 458) with videos related to

Sort By:
Pageof 46
Oncology (Williston Park, N.Y.)|May 22, 2023
Biomarkers for Response to Anti-PD-1/Anti-PD-L1 Immune Checkpoint Inhibitors: A Large Meta-AnalysisArshiya Mariam, Suneel Kamath, Kimberly Schveder, et al.
Pharmacogenomics|October 5, 2021
The need to shift pharmacogenetic research from candidate gene to genome-wide association studiesDerek W Linskey, David C Linskey, Howard L McLeod, et al.
Pharmacogenomics|April 1, 2011
Systems pharmacology assessment of the 5-fluorouracil pathwayFilipe A Muhale, Barbara A Wetmore, Russell S Thomas, et al.
Plos One|September 28, 2011
Genomewide analysis of inherited variation associated with phosphorylation of PI3K/AKT/mTOR signaling proteinsJanna E Hutz, W Aaron Manning, Michael A Province, et al.
Pharmacogenomics|December 16, 2005
Defining the opportunity for pharmacogenetic intervention in primary careGloria R Grice, Terry L Seaton, Abigail M Woodland, et al.
The Oncologist|April 7, 2018
Value of Supportive Care Pharmacogenomics in Oncology PracticeJai N Patel, Lauren A Wiebe, Henry M Dunnenberger, et al.
Pharmacogenomics|November 7, 2009
Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendationsKyle J Ellis, George A Stouffer, Howard L McLeod, et al.
Cancer Chemotherapy and Pharmacology|November 23, 2006
Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networksWeiguang Wang, Howard L McLeod, James Cassidy, et al.
Oncology Reports|March 8, 2011
RNA expression of the molecular signature genes for metastasis in colorectal cancerLuciano Carvalho, Jinsheng Yu, Gilberto Schwartsmann, et al.
Chest|December 15, 2004
The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysisChee-Keong Toh, Ee-Hwee Wong, Wan-Teck Lim, et al.
Pageof 46